Sheng Lin
- Molecular Biology top 10%
- Cancer Research top 5%
- Oncology top 10%
- Infectious Diseases top 10%
- Immunology
- Topics
- MicroRNA in disease regulation (10 papers)Head and Neck Cancer Studies (9 papers)SARS-CoV-2 and COVID-19 Research (9 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Sheng Lin
91 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 117
- Molecular Biology 715
- Cancer Research 515
- Oncology 339
- Infectious Diseases 219
- Immunology 176
Countries citing papers authored by Sheng Lin
This map shows the geographic impact of Sheng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Lin more than expected).
Fields of papers citing papers by Sheng Lin
This network shows the impact of papers produced by Sheng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Lin. The network helps show where Sheng Lin may publish in the future.
Co-authorship network of co-authors of Sheng Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Sheng Lin. A scholar is included among the top collaborators of Sheng Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng Lin. Sheng Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 7 | |
| 7 | 37 | |
| 8 | 0 | |
| 9 | 1 | |
| 10 | 8 | |
| 11 | 85 | |
| 12 | 5 | |
| 13 | 13 | |
| 14 | 6 | |
| 15 | 4 | |
| 16 | A method for standardizing intensity modulated radiation therapy planning optimization for nasopharyngeal carcinoma | 1 |
| 17 | 3 | |
| 18 | 1 | |
| 19 | 7 | |
| 20 | 3 |
About Sheng Lin
Sheng Lin is a scholar working on Otorhinolaryngology, Cancer Research and Oncology, having authored 95 papers that have together received 1.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (10 papers), Head and Neck Cancer Studies (9 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). The work is most often cited by research in Cancer Research (515 citations), Oncology (339 citations) and Infectious Diseases (219 citations). Sheng Lin has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Shaozhi Fu, Shuwei Qiu, Zifeng Wang, Tong Xiang, Ying Peng, Haixia Long, Yang Tan, Gang Lü, Dan Hu and Yimin Feng. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.